However, this evidence is inadequate because the mice in the NOD mice experiment suffered from type 1 diabetes, and there is no evidence to confirm that the cGAS–STING pathway is likewise able to inhibit the progression of diabetes in type 2 diabetes. Here, CGAS is linked to diabetes mellitus.